Harrogate-based, Yorkshire Cancer Research has revealed plans to create a ‘cancer taskforce’ for Yorkshire in a bid to tackle the region’s biggest problems.
In an ambitious new strategy launched today this week, the charity has committed to ‘close the gap’ between cancer outcomes in Yorkshire and the rest of England by providing £100m of funding over the next 10 years.
The taskforce will bring together national leaders and experts to develop practical ideas and solutions that will save 2,000 lives every year in Yorkshire by 2025.
The charity will kick-start its new strategy by focusing on four major programmes: lung cancer, early detection, clinical trials and community health projects.
Charles Rowett, Chief Executive Officer at Yorkshire Cancer Research, said:
Yorkshire is the third worst region in England in terms of incidence rates. 11 of 13 local authorities have cancer outcomes worse than the national average, but not enough is being done to combat this disparity.
With the number of people living with and beyond cancer increasing, there has never been a more important time for a major strategic regional commitment focusing on cancer prevention, minimising risks, promoting early diagnosis, pioneering new treatments and delivering more effective care and support at every stage of the cancer patient’s journey.
- Lung cancer is the most common cancer in Yorkshire, with incidence rates nearly 20% higher than the national average.
- It is also the most common cause of cancer death in the county.
- More than 3,000 people in Yorkshire died from lung cancer in 2013
- The mortality rate in Hull is almost twice the national average.
Medical professionals, academic researchers, members of Public Health England and representatives from CCGs and local authorities will meet in January to discuss what can be done to improve lung cancer outcomes and increase the early diagnosis of all cancer types.
Further funds will be invested in developing the charity’s clinical trials. As well as bringing pioneering treatments and medical advances to cancer patients in Yorkshire, the investment will attract national experts and emerging talent to the region.
Yorkshire Cancer Research will also invest in community health projects to raise awareness, increase participation in national screening programmes for bowel, breast and cervical cancer and sign-post people to the best services and support.
With people in Yorkshire being more likely to get cancer, and more likely to die from it, it is vital that we act as a catalyst for change and attract more research investment into our region from central and local government, national charities and other organisations to address the enormous challenges that exist in Yorkshire.